2024 |
Sage Therapeutics Inc
|
Independent Director |
425.1 K |
- |
2024 |
Allogene Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
UroGen Pharma Ltd
|
Director, President and Chief Executive Officer |
- |
- |
2023 |
Allogene Therapeutics Inc
|
Independent Director |
476.4 K |
-1.4 % |
2023 |
UroGen Pharma Ltd
|
Director, President and Chief Executive Officer |
- |
- |
2023 |
Sage Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
Allogene Therapeutics Inc
|
Independent Director |
483.3 K |
-44.0 % |
2022 |
Sage Therapeutics Inc
|
Independent Director |
267.4 K |
-50.6 % |
2022 |
UroGen Pharma Ltd
|
Director, President and Chief Executive Officer |
- |
- |
2021 |
Allogene Therapeutics Inc
|
Independent Director |
863.3 K |
- |
2021 |
Sage Therapeutics Inc
|
Independent Director |
540.9 K |
85.4 % |
2021 |
UroGen Pharma Ltd
|
Director, President and Chief Executive Officer |
- |
- |
2020 |
Sage Therapeutics Inc
|
Independent Director |
291.7 K |
-89.8 % |
2020 |
UroGen Pharma Ltd
|
Director, President and Chief Executive Officer |
- |
- |
2019 |
Sage Therapeutics Inc
|
Director |
2.8 M |
- |
2019 |
UroGen Pharma Ltd
|
Director, President and Chief Executive Officer |
- |
- |
2018 |
Sage Therapeutics Inc
|
Director |
- |
- |
2018 |
UroGen Pharma Ltd
|
President, Director and Chief Executive Officer |
- |
- |